Charlene Denham

449 total citations
9 papers, 360 citations indexed

About

Charlene Denham is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Charlene Denham has authored 9 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Charlene Denham's work include HIV/AIDS drug development and treatment (1 paper), Synthesis and Biological Evaluation (1 paper) and T-cell and Retrovirus Studies (1 paper). Charlene Denham is often cited by papers focused on HIV/AIDS drug development and treatment (1 paper), Synthesis and Biological Evaluation (1 paper) and T-cell and Retrovirus Studies (1 paper). Charlene Denham collaborates with scholars based in United States and Ukraine. Charlene Denham's co-authors include Vincent T. Oliverio, Vincent T. DeVita, Jack D. Davidson, Richard H. Adamson, T. Phillip Waalkes, Edward S. Henderson, DeVita Vt, Oliverio Vt, Charles L. Vogel and Seymour Perry and has published in prestigious journals such as Analytical Biochemistry, Life Sciences and Journal of Pharmaceutical Sciences.

In The Last Decade

Charlene Denham

9 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlene Denham United States 7 98 70 65 49 42 9 360
C. P. Rhoads United States 10 140 1.4× 74 1.1× 138 2.1× 33 0.7× 30 0.7× 20 453
Richard W. Dyke United States 10 192 2.0× 157 2.2× 30 0.5× 40 0.8× 19 0.5× 13 415
H. J. Tagnon Belgium 13 104 1.1× 116 1.7× 27 0.4× 19 0.4× 49 1.2× 38 491
Kathryn N. Ham Australia 12 119 1.2× 50 0.7× 22 0.3× 24 0.5× 25 0.6× 23 460
Samuel Bieber United Kingdom 10 329 3.4× 33 0.5× 97 1.5× 74 1.5× 17 0.4× 14 590
Tomofusa Usui Japan 14 120 1.2× 48 0.7× 39 0.6× 39 0.8× 14 0.3× 33 403
Herbert Arnold Austria 8 86 0.9× 70 1.0× 49 0.8× 13 0.3× 10 0.2× 21 414
J E Wright United States 12 225 2.3× 135 1.9× 95 1.5× 47 1.0× 10 0.2× 18 636
Myung S. Rhee United States 15 269 2.7× 115 1.6× 152 2.3× 39 0.8× 36 0.9× 32 586
T J Fraser United States 8 424 4.3× 207 3.0× 54 0.8× 24 0.5× 34 0.8× 9 686

Countries citing papers authored by Charlene Denham

Since Specialization
Citations

This map shows the geographic impact of Charlene Denham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlene Denham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlene Denham more than expected).

Fields of papers citing papers by Charlene Denham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlene Denham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlene Denham. The network helps show where Charlene Denham may publish in the future.

Co-authorship network of co-authors of Charlene Denham

This figure shows the co-authorship network connecting the top 25 collaborators of Charlene Denham. A scholar is included among the top collaborators of Charlene Denham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlene Denham. Charlene Denham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Vogel, Charles L., Charlene Denham, T. Phillip Waalkes, & Vincent T. DeVita. (1970). The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs.. PubMed. 30(6). 1651–7. 15 indexed citations
2.
Waalkes, T. Phillip, Charlene Denham, & Vincent T. DeVita. (1970). Pentamidine: Clinical pharmacologic correlations in man and mice. Clinical Pharmacology & Therapeutics. 11(4). 505–512. 65 indexed citations
3.
DeVita, Vincent T., Charlene Denham, & Seymour Perry. (1969). Relationship of normal CDF1 mouse leukocyte kinetics to growth characteristics of leukemia L1210.. PubMed. 29(5). 1067–71. 5 indexed citations
4.
DeVita, Vincent T., Charlene Denham, Jack D. Davidson, & Vincent T. Oliverio. (1967). The physiological disposition of the carcinostatic 1,3‐bis(2‐chloroethyU‐l‐nitrosourea (BCNU) in man and animals. Clinical Pharmacology & Therapeutics. 8(4). 566–577. 80 indexed citations
5.
Henderson, Edward S., Richard H. Adamson, Charlene Denham, & Vincent T. Oliverio. (1965). The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys.. PubMed. 25(7). 1008–17. 98 indexed citations
6.
Vt, Oliverio, et al.. (1964). SOME PHARMACOLOGIC PROPERTIES OF A NEW ANTITUMOR AGENT, N-ISOPROPYL-ALPHA-(2-METHYLHYDRAZINO)-P-TOLUAMIDE, HYDROCHLORIDE (NSC-77213).. PubMed. 42. 1–7. 20 indexed citations
7.
Adamson, Richard H., Vincent T. Oliverio, Charlene Denham, & John M. Venditti. (1963). Concentration of methylglyoxal-bis-guanylhydrazone-C14 in mouse leukemia L1210 and a resistant variant. Life Sciences. 2(7). 493–496. 1 indexed citations
8.
Oliverio, Vincent T. & Charlene Denham. (1963). Synthesis of Methylglyoxal-bis-guanylhydrazone-C14. Journal of Pharmaceutical Sciences. 52(2). 202–203. 9 indexed citations
9.
Oliverio, Vincent T., Charlene Denham, & Jack D. Davidson. (1962). Oxygen flask combustion in determination of C14 and H3 in biological materials. Analytical Biochemistry. 4(2). 187–189. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. P. Rhoads Breakdown of academic impact, for papers by Richard W. Dyke Breakdown of academic impact, for papers by H. J. Tagnon Breakdown of academic impact, for papers by Kathryn N. Ham Breakdown of academic impact, for papers by Samuel Bieber Breakdown of academic impact, for papers by Tomofusa Usui Breakdown of academic impact, for papers by Herbert Arnold Breakdown of academic impact, for papers by J E Wright Breakdown of academic impact, for papers by Myung S. Rhee Breakdown of academic impact, for papers by T J Fraser
Rankless by CCL
2026